These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
105 related articles for article (PubMed ID: 25765394)
1. Re: Randomized and double-blinded clinical trial of the safety and calcium kidney stone dissolving efficacy of Lapis judaicus. Assimos DG J Urol; 2015 Mar; 193(3):897-8. PubMed ID: 25765394 [No Abstract] [Full Text] [Related]
2. Re: Editorial Comment on Randomized and Double-Blinded Clinical Trial of the Safety and Calcium Kidney Stone Dissolving Efficacy of Lapis Judaicus: D. G. Assimos J Urol 2015;193:897-898. Faridi P; Mohagheghzadeh A; Roozbeh J J Urol; 2015 Jul; 194(1):267. PubMed ID: 25862236 [No Abstract] [Full Text] [Related]
3. Randomized and double-blinded clinical trial of the safety and calcium kidney stone dissolving efficacy of Lapis judaicus. Faridi P; Seradj H; Mohammadi-Samani S; Vossoughi M; Mohagheghzadeh A; Roozbeh J J Ethnopharmacol; 2014 Oct; 156():82-7. PubMed ID: 25193008 [TBL] [Abstract][Full Text] [Related]
4. A comparative pilot study of litholytic properties of Celosia argental (Sitivaraka) versus potassium citrate in renal calculus disease. Singh RG; Singh TB; Kumar R; Dwivedi US; Moorthy KN; Kumar N J Altern Complement Med; 2012 May; 18(5):427-8. PubMed ID: 22537564 [No Abstract] [Full Text] [Related]
5. [Prolit in the treatment and prophylaxis of nephrolithiasis]. Borisov VV; Koptev VV; Enaleeva SK; Demerza IuA Urologiia; 2004; (2):38-40. PubMed ID: 15114752 [TBL] [Abstract][Full Text] [Related]
6. Hajrul yahood (Lapis judaicus): An important mineral drug of Unani system of medicine for the management of urolithiasis. Makbul SAA; Jahan N; Ahmad G J Ethnopharmacol; 2018 Aug; 222():165-170. PubMed ID: 29733943 [TBL] [Abstract][Full Text] [Related]
7. Role of stone analysis in metabolic evaluation and medical treatment of nephrolithiasis. Kourambas J; Aslan P; Teh CL; Mathias BJ; Preminger GM J Endourol; 2001 Mar; 15(2):181-6. PubMed ID: 11325090 [TBL] [Abstract][Full Text] [Related]
8. Eicosapentaenoic acid has a preventive effect on the recurrence of nephrolithiasis. Yasui T; Suzuki S; Itoh Y; Tozawa K; Tokudome S; Kohri K Urol Int; 2008; 81(2):135-8. PubMed ID: 18758209 [TBL] [Abstract][Full Text] [Related]
9. Pharmacological and toxicological effects of Paronychia argentea in experimental calcium oxalate nephrolithiasis in rats. Bouanani S; Henchiri C; Migianu-Griffoni E; Aouf N; Lecouvey M J Ethnopharmacol; 2010 May; 129(1):38-45. PubMed ID: 20138208 [TBL] [Abstract][Full Text] [Related]
12. Magnesium therapy for nephrolithiasis. Massey L Magnes Res; 2005 Jun; 18(2):123-6. PubMed ID: 16100850 [TBL] [Abstract][Full Text] [Related]
13. The effects of allopurinol treatment on stone formation on hyperuricosuric calcium oxalate stone-formers. Favus MJ; Coe FL Scand J Urol Nephrol Suppl; 1980; 53():265-71. PubMed ID: 6938003 [TBL] [Abstract][Full Text] [Related]
14. Evaluation and medical management of kidney stones in children. Tasian GE; Copelovitch L J Urol; 2014 Nov; 192(5):1329-36. PubMed ID: 24960469 [TBL] [Abstract][Full Text] [Related]
15. Citrate and renal calculi. Pak CY Miner Electrolyte Metab; 1987; 13(4):257-66. PubMed ID: 3306318 [TBL] [Abstract][Full Text] [Related]
16. Outcome of metabolic evaluation and medical treatment for calcium nephrolithiasis in a private urological practice. Mardis HK; Parks JH; Muller G; Ganzel K; Coe FL J Urol; 2004 Jan; 171(1):85-8. PubMed ID: 14665850 [TBL] [Abstract][Full Text] [Related]
17. [What has been achieved in the therapy of calcium nephrolithiasis?]. Tschöpe W; Ritz E Internist (Berl); 1979 Dec; 20(12):599-606. PubMed ID: 398355 [No Abstract] [Full Text] [Related]
18. Urinary alkalization for the treatment of uric acid nephrolithiasis. Cicerello E; Merlo F; Maccatrozzo L Arch Ital Urol Androl; 2010 Sep; 82(3):145-8. PubMed ID: 21121431 [TBL] [Abstract][Full Text] [Related]
19. Ayurvedic medicine and renal calculi. Kieley S; Dwivedi R; Monga M J Endourol; 2008 Aug; 22(8):1613-6. PubMed ID: 18620498 [TBL] [Abstract][Full Text] [Related]